Antibiotic prophylaxis for gynecologic procedures.

GUIDELINE TITLE
Antibiotic prophylaxis for gynecologic procedures.

BIBLIOGRAPHIC SOURCE(S)
American College of Obstetricians and Gynecologists (ACOG). Antibiotic prophylaxis for gynecologic procedures. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2009 May. 10 p. (ACOG practice bulletin; no. 104). [55 references]

GUIDELINE STATUS
This is the current release of the guideline.

This guideline updates a previous version: American College of Obstetricians and Gynecologists (ACOG). Antibiotic prophylaxis for gynecologic procedures. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2006 Jul. 10 p. (ACOG practice bulletin; no. 74).

** REGULATORY ALERT **
FDA WARNING/REGULATORY ALERT
Note from the National Guideline Clearinghouse: This guideline references a drug(s) for which important revised regulatory and/or warning information has been released.

December 11, 2008 - Oral sodium phosphate products (prescription and over-the-counter): The U.S. Food and Drug Administration (FDA) is requiring the manufacturer of Visicol and OsmoPrep, the two oral sodium phosphate products (OSPs) available by prescription only, to add a Boxed Warning to the labeling for these products. The FDA recommends, in light of the risk of acute phosphate nephropathy, over-the-counter laxative OSP products should not be used for bowel cleansing. Consumers should only use OSPs for bowel cleansing pursuant to a prescription from a healthcare professional.

abrir aquí para acceder al documento NGC AHRQ completo:
Antibiotic prophylaxis for gynecologic procedures.